Insider Transactions in Q2 2022 at Genocea Biosciences, Inc. (GNCA)
Insider Transaction List (Q2 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 02
2022
|
William D Clark President and CEO |
SELL
Open market or private sale
|
Direct |
4,023
-1.3%
|
$0
$0.06 P/Share
|
Jun 02
2022
|
Jessica Baker Flechtner Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,578
-1.74%
|
$0
$0.06 P/Share
|
Jun 02
2022
|
Diantha Duvall CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,355
-1.77%
|
$0
$0.06 P/Share
|
Jun 01
2022
|
Jacquelyn L Sumer CHIEF LEGAL & COMPLIANCE OFF |
SELL
Open market or private sale
|
Direct |
2,500
-5.49%
|
$0
$0.06 P/Share
|
May 31
2022
|
William D Clark President and CEO |
SELL
Open market or private sale
|
Direct |
117,244
-27.55%
|
$0
$0.06 P/Share
|
May 27
2022
|
George Siber Director |
SELL
Open market or private sale
|
Direct |
20,425
-98.78%
|
$0
$0.07 P/Share
|
May 26
2022
|
Diantha Duvall CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
24,407
-24.13%
|
$0
$0.08 P/Share
|
May 25
2022
|
Jessica Baker Flechtner Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
16,525
-15.43%
|
$0
$0.09 P/Share
|
May 25
2022
|
Raymond D Stapleton Jr CHIEF TECHNOLOGY OFFICER |
SELL
Open market or private sale
|
Direct |
2,500
-5.41%
|
$0
$0.09 P/Share
|
May 25
2022
|
Forest Baskett > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
4,445,093
-100.0%
|
$0
$0.08 P/Share
|
May 25
2022
|
Ali Behbahani Director |
SELL
Open market or private sale
|
Indirect |
4,445,093
-100.0%
|
$0
$0.08 P/Share
|
May 25
2022
|
Carmen Chang > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
4,445,093
-100.0%
|
$0
$0.08 P/Share
|
May 25
2022
|
Anthony A. Florence Jr. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
4,445,093
-100.0%
|
$0
$0.08 P/Share
|
May 25
2022
|
Mohamad Makhzoumi > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
4,445,093
-100.0%
|
$0
$0.08 P/Share
|
May 25
2022
|
New Enterprise Associates 16, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,445,093
-100.0%
|
$0
$0.08 P/Share
|
May 25
2022
|
Scott D Sandell > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
4,445,093
-100.0%
|
$0
$0.08 P/Share
|
May 25
2022
|
Peter W. Sonsini > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
4,445,093
-100.0%
|
$0
$0.08 P/Share
|
May 25
2022
|
Paul Edward Walker > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
4,445,093
-100.0%
|
$0
$0.08 P/Share
|
May 24
2022
|
Forest Baskett > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
5,931,843
-57.16%
|
$0
$0.07 P/Share
|
May 24
2022
|
Ali Behbahani Director |
SELL
Open market or private sale
|
Indirect |
5,931,843
-57.16%
|
$0
$0.07 P/Share
|
May 24
2022
|
Carmen Chang > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
5,931,843
-57.16%
|
$0
$0.07 P/Share
|
May 24
2022
|
Anthony A. Florence Jr. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
5,931,843
-57.16%
|
$0
$0.07 P/Share
|
May 24
2022
|
Mohamad Makhzoumi > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
5,931,843
-57.16%
|
$0
$0.07 P/Share
|
May 24
2022
|
New Enterprise Associates 16, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,931,843
-57.16%
|
$0
$0.07 P/Share
|
May 24
2022
|
Scott D Sandell > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
5,931,843
-57.16%
|
$0
$0.07 P/Share
|
May 24
2022
|
Peter W. Sonsini > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
5,931,843
-57.16%
|
$0
$0.07 P/Share
|
May 24
2022
|
Paul Edward Walker > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
5,931,843
-57.16%
|
$0
$0.07 P/Share
|
Apr 04
2022
|
Girish N Aakalu CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
963
-1.28%
|
$963
$1.25 P/Share
|
Apr 04
2022
|
William D Clark President and CEO |
SELL
Open market or private sale
|
Direct |
3,924
-1.05%
|
$3,924
$1.25 P/Share
|
Apr 04
2022
|
Thomas Andrew Davis CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,091
-1.57%
|
$1,091
$1.25 P/Share
|
Apr 04
2022
|
Diantha Duvall CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
963
-1.04%
|
$963
$1.25 P/Share
|
Apr 04
2022
|
Jessica Baker Flechtner Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,212
-1.24%
|
$1,212
$1.25 P/Share
|